At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MRNY YieldMax MRNA Option Income Strategy ETF
Market Closed 10-23 16:00:00 EDT
38.21
-0.88
-2.25%
盘后38.00
-0.21-0.55%
19:54 EDT
High39.30Low34.77Vol482.04K
Open37.35D1 Closing39.09Amplitude11.58%
Mkt Cap211.30MTradable Cap211.30MTotal Shares5.53M
T/O18.20MT/O Rate8.72%Tradable Shares5.53M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

A 42% Risk Reduction—and an 18% Stock Drop
Bellwether Stocks Movement  ·  10-24 22:29
A 42% Risk Reduction—and an 18% Stock Drop
Moderna Publishes Presentation on Phase I Intismeran Study in Resected Pancreatic Cancer
Reuters  ·  10-25 21:32
Moderna Publishes Presentation on Phase I Intismeran Study in Resected Pancreatic Cancer
Moderna Publishes Presentation on Phase 3 Intismeran Melanoma Study
Reuters  ·  10-25 01:05
Moderna Publishes Presentation on Phase 3 Intismeran Melanoma Study
Friday’s Winners And Losers Had One Thing In Common
Bellwether Stocks Movement  ·  10-24 23:16
Friday’s Winners And Losers Had One Thing In Common
Moderna Investors Should Brace for More Whiplash
Dow Jones  ·  10-24 17:30
Moderna Investors Should Brace for More Whiplash
Moderna’s Cancer Vaccine Passed Phase 3. What Spooked Investors?
Bellwether Stocks Movement  ·  10-24 12:44
Moderna’s Cancer Vaccine Passed Phase 3. What Spooked Investors?
Moderna's Cancer Vaccine Success Doesn't Live up to Early Hype
Dow Jones  ·  10-24 07:00
Moderna's Cancer Vaccine Success Doesn't Live up to Early Hype
Moderna’s Cancer Vaccine Earns Praise from Doctors amid Stock Selloff
TIPRANKS  ·  10-24 03:04
Moderna’s Cancer Vaccine Earns Praise from Doctors amid Stock Selloff
Moderna Executives Sold Shares in Trades Planned Before Vaccine Results
Dow Jones  ·  10-24 03:02
Moderna Executives Sold Shares in Trades Planned Before Vaccine Results
The Real Test for Moderna's Cancer Vaccine Isn't About Beating Keytruda. It's Keeping Cancer from Coming Back in the Long Term.
Dow Jones  ·  10-24 02:58
The Real Test for Moderna's Cancer Vaccine Isn't About Beating Keytruda. It's Keeping Cancer from Coming Back in the Long Term.
Think Annuities are a Rip-Off? Now Might be the Perfect Time to Reconsider.
Dow Jones  ·  10-24 02:43
Think Annuities are a Rip-Off? Now Might be the Perfect Time to Reconsider.
Moderna's Cancer-Vaccine Leak Spurs Panic Selling. Wall Street Wanted a Cure.
Dow Jones  ·  10-24 02:27
Moderna's Cancer-Vaccine Leak Spurs Panic Selling. Wall Street Wanted a Cure.
Moderna’s Norovirus Vaccine Trial Reaches Key Milestone, Supporting Its Post-COVID Growth Story
TIPRANKS  ·  10-24 00:30
Moderna’s Norovirus Vaccine Trial Reaches Key Milestone, Supporting Its Post-COVID Growth Story
Moderna Shares Reverse Course; Last up 1.7%
THOMSON REUTERS  ·  10-24 00:20
Moderna Shares Reverse Course; Last up 1.7%
ESMO Says not Able to Establish Precise Circumstances That Led to Moderna-Merck Data Leak
Reuters  ·  10-23 21:49
ESMO Says not Able to Establish Precise Circumstances That Led to Moderna-Merck Data Leak
Esmo on Moderna-Merck Data Leak: Cannot Determine Whether the Incident Resulted from Human Error, a Technical Issue, or Another Cause
THOMSON REUTERS  ·  10-23 21:37
Esmo on Moderna-Merck Data Leak: Cannot Determine Whether the Incident Resulted from Human Error, a Technical Issue, or Another Cause
Esmo on Moderna-Merck Data Leak: not Able to Establish Precise Circumstances That Led to the Publication of Embargoed Information
THOMSON REUTERS  ·  10-23 21:37
Esmo on Moderna-Merck Data Leak: not Able to Establish Precise Circumstances That Led to the Publication of Embargoed Information
Sector Update: Healthcare
MT Newswires Live  ·  10-23 21:02
Sector Update: Healthcare
Why Is Moderna Stock (MRNA) Still Falling After Thursday’s 18% Plunge?
TIPRANKS  ·  10-23 20:01
Why Is Moderna Stock (MRNA) Still Falling After Thursday’s 18% Plunge?
Stock Market Reels from 2 World-Changing Factors
Dow Jones  ·  10-23 19:41
Stock Market Reels from 2 World-Changing Factors
No data available

Introduction

Company Name.
YieldMax MRNA Option Income Strategy ETF
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
The fund advisor will seek to employ the fund's investment strategy as the fund relates to MRNA regardless of whether there are periods of adverse market, economic, or other conditions and will not seek to take temporary defensive positions during such periods. The fund is non-diversified.
Issue price:
--